TPG heads into its August 6 earnings report with the Street turning more constructive in real time, four analysts lifting price targets on the day of results.
The analyst response has been swift and one-directional. Keefe Bruyette, RBC Capital, Barclays, and Evercore ISI all raised targets on August 5 — the day after the print dropped — keeping their existing ratings intact. RBC pushed its target to $65 and Barclays to $64, both well above the current $48.98. The mean consensus target now sits at $58.44, implying roughly 19% further upside from here. The only dissenting move came from Morgan Stanley two weeks ago, when the firm trimmed its Equal-Weight target from $60 to $54 — a cautious stance that now looks out of step with the post-results reaction. The analyst rec differentiation score ranks in the 91st percentile, meaning TPG sits near the top of the universe for divergence between bull and bear cases on the Street.
Positioning reflects the same sentiment reset flagged in the prior note, but it has moved further. The put/call ratio now reads 1.42, nearly 1.4 standard deviations below its 20-day mean of 3.03 — a dramatic unwind from the heavy put-loading that dominated through June and most of July, when the PCR sat near 4-5. That collapse in downside protection demand lines up almost exactly with the stock's 18% monthly gain. The borrow market adds little pressure from the other direction: availability remains abundant at roughly 9x current short interest, and borrowing costs, while up 12% on the week to 0.46%, are still near their lowest level of the past month. Short interest at 8.4% of the free float is not negligible — days to cover run at 7.3 — but the position has barely budged week-on-week, down just 0.1%, suggesting shorts are neither pressing nor fleeing.
The peer group has broadly participated in the same rally. HLNE led the group on the week, up 13.5%, while OWL gained nearly 18%. ARES added 11.7%, almost matching TPG's 11.9% weekly move. KKR and BX lagged, up 5.4% and 2.5% respectively, suggesting the re-rating has been more pronounced in mid-cap alternative managers than in the large-cap flagships. CG rose 9%, broadly in line. The sectoral bid appears real, but TPG's move is tracking near the top of the peer distribution rather than merely riding the wave.
Institutional holders going into this period include Temasek at 6.2% and Darlington Partners at 5.6% — the latter having added over four million shares in the quarter to March. Millennium and Wellington each built positions of roughly five percent over the same period. The insider picture is less encouraging: founder James Coulter sold 41,000 shares at $43.15 on July 15, just before the most recent leg of the rally. CEO Jon Winkelried and CFO Jack Weingart both sold sizeable positions in January at $66 — a price that now looks elevated relative to the current $48.98. The insider selling has all been at prices above the current level, which frames the recent analyst enthusiasm as recovering from a deeper drawdown rather than validating a new high.
Forward EPS momentum is the standout factor, ranking in the 86th percentile on a 12-month forward year-on-year basis. The dividend score ranks in the 93rd percentile, though the dividend history in the data is over four years old and should be treated with caution. The short score of 54.6 is mid-range and has been stable, consistent with a stock where short interest exists but is not driving the tape. The earnings results themselves — delivered after the close on August 4 — are the event that has now catalysed the analyst target upgrades, and the next focus will be whether the post-results price can hold above $50 or whether the gap between the current price and the elevated January insider sale levels reasserts itself as resistance.
See the live data behind this article on ORTEX.
Open TPG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
